Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies.

Front Mol Biosci · 2025 · PMC12146366 · PMID 40492115

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The frequency of treatment failure may be significant in patients treated with MIL, which has supplanted antimonials in the kala-azar extermination campaign in nations such as India, even though it has been noted in patients treated with the majority of anti-leishmanials.

also in 7,483 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.